DBV Technologies S.A. DBVT

Latest FY: 2025 Healthcare Biotechnology
Market Price $13.74
Market Cap $4.07B
P/E Ratio N/A
Quick Peer Compare (Healthcare):
Revenue (FY 2025) ↑35.8% YoY
$5.64M
3-Yr CAGR: 5.2%
Net Income ↓-229.0% YoY
-$146.95M
Net Margin: -2,607.3%
Free Cash Flow ↓-14.0% YoY
-$121.71M
FCF Yield: -2.99%
EPS (Diluted) ↑10.3% YoY
$-1.05
Basic: $-1.05
Return on Equity Efficiency
-87.1%
ROA: -1,717.9%

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (DBVT)

All monetary values in millions ($M)
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Div / Sh Div Yield Op. Cash Flow Free Cash Flow FCF YoY
FY 2016 $20.5M $2.6M $-4.68 0.00% $-59.5M $-60.0M
FY 2017 $18.7M $-12.4M -576.1% $-5.97 -27.6% 0.00% $-114.3M $-115.2M -91.8%
FY 2018 $-6.0M $-72.0M -482.6% $-5.74 +3.9% 0.00% $-136.6M $-136.8M -18.8%
FY 2019 $0.6M $-35.7M +50.4% $-4.15 +27.7% 0.00% $-128.5M $-128.6M +6.0%
FY 2020 $11.3M $1.6M $-159.6M -346.5% $-12.97 -212.5% 0.00% $-165.6M $-168.3M -30.9%
FY 2021 $5.7M -49.4% $2.6M $-97.8M +38.7% $-89.80 -592.4% 0.00% $-108.2M $-109.2M +35.2%
FY 2022 $4.8M -15.1% $5.5M $-96.3M +1.6% $-1.24 +98.6% 0.00% $-55.7M $-56.4M +48.3%
FY 2023 $15.7M +224.7% $3.9M $-72.7M +24.5% $-0.76 +38.7% 0.00% $-79.7M $-80.3M -42.4%
FY 2024 $4.2M -73.6% $5.8M $113.9M +256.6% $-1.17 -53.9% 0.00% $-104.5M $-106.8M -33.0%
FY 2025 $5.6M +35.8% $0.5M $-146.9M -229.0% $-1.05 +10.3% 0.00% $-121.2M $-121.7M -14.0%
$

Valuation

Market Price $13.74
Market Cap $4.07B
Enterprise Value $4.07B
P/E Ratio N/A
P/B Ratio 24.10
FCF Yield -2.99%
Dividend Yield 0.00%
Shares Outstanding 296,042,447
%

Profitability & Margins

Gross Margin 8.87%
Operating Margin -2,598.58%
Net Margin -2,607.29%
Return on Equity (ROE) -87.07%
Return on Assets (ROA) -1,717.87%
Asset Turnover 0.66x
Revenue 3-Yr CAGR 5.18%
🛡️

Financial Health & Liquidity

Current Ratio 3.67
Cash Ratio 0.05
Debt / Equity 0.000
Debt / Assets 0.000
Cash & Equivalents $2.62M
Total Debt N/A
Book Value / Share $0.57
💧

Cash Flow Efficiency

Operating Cash Flow -$121.18M
Capital Expenditures (CapEx) $532.00K
Free Cash Flow -$121.71M
OCF / Revenue -2,150.12%
FCF / Revenue -2,159.56%
FCF 3-Yr CAGR N/A
🏷️

Per Share Metrics

EPS (Diluted) $-1.05
EPS (Basic) $-1.05
Dividends / Share N/A
Book Value / Share $0.57
EPS YoY Growth 10.26%
🏛️

Balance Sheet (FY 2025)

Total Assets $8.55M
Total Liabilities -$160.22M
Stockholders' Equity $168.77M
Current Assets $212.94M
Current Liabilities $58.02M